{"log_id": 4043483674954898176, "direction": 0, "words_result_num": 54, "words_result": [{"probability": {"variance": 0.019411, "average": 0.921031, "min": 0.462553}, "location": {"width": 743, "top": 184, "height": 70, "left": 180}, "words": "洲人,7为其他人种、每个试验设计: Caspar的给药方案在不同治疗组有所不同"}, {"probability": {"variance": 0.066455, "average": 0.719434, "min": 0.424583}, "location": {"width": 54, "top": 179, "height": 25, "left": 987}, "words": "a\"间"}, {"probability": {"variance": 0.024738, "average": 0.919327, "min": 0.463086}, "location": {"width": 822, "top": 239, "height": 73, "left": 221}, "words": "在研究1中,收集按照儿童肿瘤协作组(CC毒性租并发症标准确定4级非血液性不良反应利"}, {"probability": {"variance": 0.029966, "average": 0.882015, "min": 0.454999}, "location": {"width": 226, "top": 246, "height": 38, "left": 183}, "words": "镇缩药时间最多达1个月"}, {"probability": {"variance": 0.013633, "average": 0.950135, "min": 0.468011}, "location": {"width": 847, "top": 269, "height": 76, "left": 187}, "words": "门冬酰胺酶导致的特定的不良反应信息。每个治疗维每个患者34级的严重程度的毒性反应列于表"}, {"probability": {"variance": 0, "average": 0.896102, "min": 0.896102}, "location": {"width": 21, "top": 352, "height": 21, "left": 187}, "words": "中"}, {"probability": {"variance": 0.011636, "average": 0.966951, "min": 0.495523}, "location": {"width": 413, "top": 345, "height": 54, "left": 351}, "words": "表1:研究1:每个患奢发生的34级不良反应"}, {"probability": {"variance": 0.018912, "average": 0.936466, "min": 0.514074}, "location": {"width": 215, "top": 369, "height": 36, "left": 718}, "words": "大肠杆菌左旋门冬酰胺酶"}, {"probability": {"variance": 5e-06, "average": 0.996951, "min": 0.994616}, "location": {"width": 21, "top": 420, "height": 19, "left": 615}, "words": "58"}, {"probability": {"variance": 3.7e-05, "average": 0.996773, "min": 0.982064}, "location": {"width": 126, "top": 463, "height": 32, "left": 264}, "words": "肝功能检测异常"}, {"probability": {"variance": 0.00926, "average": 0.932367, "min": 0.65729}, "location": {"width": 183, "top": 491, "height": 33, "left": 287}, "words": "转氨酶升高(ALT和AS"}, {"probability": {"variance": 0.059586, "average": 0.767933, "min": 0.362357}, "location": {"width": 40, "top": 482, "height": 20, "left": 594}, "words": "(3%"}, {"probability": {"variance": 0.004363, "average": 0.885046, "min": 0.773842}, "location": {"width": 100, "top": 530, "height": 24, "left": 289}, "words": "高胆红素血"}, {"probability": {"variance": 4.5e-05, "average": 0.993019, "min": 0.986318}, "location": {"width": 32, "top": 532, "height": 20, "left": 832}, "words": "%)"}, {"probability": {"variance": 0, "average": 0.990212, "min": 0.990212}, "location": {"width": 19, "top": 546, "height": 18, "left": 615}, "words": "%"}, {"probability": {"variance": 0.047138, "average": 0.848064, "min": 0.474049}, "location": {"width": 69, "top": 564, "height": 22, "left": 272}, "words": "高度糖症"}, {"probability": {"variance": 0, "average": 0.998493, "min": 0.998493}, "location": {"width": 19, "top": 564, "height": 19, "left": 834}, "words": "%"}, {"probability": {"variance": 0.03428, "average": 0.786897, "min": 0.459669}, "location": {"width": 135, "top": 587, "height": 34, "left": 277}, "words": "中枢神经系绕维栓"}, {"probability": {"variance": 0.001679, "average": 0.980388, "min": 0.888852}, "location": {"width": 102, "top": 622, "height": 27, "left": 277}, "words": "凝血功能异常"}, {"probability": {"variance": 0.006929, "average": 0.949841, "min": 0.749445}, "location": {"width": 138, "top": 649, "height": 29, "left": 294}, "words": "凝血原时间延长"}, {"probability": {"variance": 0.004083, "average": 0.959723, "min": 0.78288}, "location": {"width": 172, "top": 674, "height": 39, "left": 296}, "words": "部分凝血活酶时间延长"}, {"probability": {"variance": 0.000948, "average": 0.977471, "min": 0.918531}, "location": {"width": 142, "top": 708, "height": 36, "left": 295}, "words": "低纤维蛋白原血症"}, {"probability": {"variance": 0.000547, "average": 0.981268, "min": 0.948217}, "location": {"width": 43, "top": 730, "height": 22, "left": 607}, "words": "(2%"}, {"probability": {"variance": 0.007851, "average": 0.92204, "min": 0.796801}, "location": {"width": 53, "top": 749, "height": 24, "left": 283}, "words": "胰腺炎"}, {"probability": {"variance": 0, "average": 0.995488, "min": 0.995488}, "location": {"width": 19, "top": 763, "height": 19, "left": 629}, "words": "%"}, {"probability": {"variance": 0.007094, "average": 0.97086, "min": 0.580744}, "location": {"width": 824, "top": 764, "height": 77, "left": 245}, "words": "研究2中仪收集按照美国国立癌症研究所通用毒性标准( NCI CTC)2.0版规定的3~4级非血液"}, {"probability": {"variance": 0.006927, "average": 0.955812, "min": 0.693112}, "location": {"width": 226, "top": 767, "height": 42, "left": 282}, "words": "对门冬酰胺酶的临床过敏反应"}, {"probability": {"variance": 0.002554, "average": 0.982202, "min": 0.717876}, "location": {"width": 862, "top": 795, "height": 79, "left": 207}, "words": "学毒性。在这个研究中,每个患者在接受 Oncaspat治疗的过程中发生的不良反应及发生率为:转氨酶"}, {"probability": {"variance": 0.008354, "average": 0.963973, "min": 0.602993}, "location": {"width": 857, "top": 827, "height": 78, "left": 209}, "words": "升高,11%:凝血功能异常,7%;高糖血症,5%;中枢神经系统血栓,2%:胰腺炎,2%;临床过"}, {"probability": {"variance": 0.002314, "average": 0.980077, "min": 0.789733}, "location": {"width": 494, "top": 878, "height": 56, "left": 211}, "words": "敏反应,1%;高胆红素血症,1%。胰腺炎导致3人死亡"}, {"probability": {"variance": 0.005128, "average": 0.980365, "min": 0.703155}, "location": {"width": 319, "top": 917, "height": 45, "left": 252}, "words": "经治的急性淋巴细胞白血病复发治疗"}, {"probability": {"variance": 0.006435, "average": 0.978665, "min": 0.569414}, "location": {"width": 508, "top": 935, "height": 57, "left": 254}, "words": "不良反应信息从5个临床试验获得,其中包括174名接受Or"}, {"probability": {"variance": 0.000434, "average": 0.991447, "min": 0.92047}, "location": {"width": 252, "top": 921, "height": 35, "left": 823}, "words": "作为单药治疗或联合治疗的复"}, {"probability": {"variance": 0.00463, "average": 0.983112, "min": 0.58767}, "location": {"width": 840, "top": 948, "height": 78, "left": 217}, "words": "发的急性淋巴细胞白血病患者。除了临床的过敏反应,在经治复发的急性淋巴细胞白血病患者"}, {"probability": {"variance": 0.005497, "average": 0.980797, "min": 0.599315}, "location": {"width": 579, "top": 994, "height": 63, "left": 229}, "words": " )caspar的毒性反应特点与上述报告的病例是类似的(见表2)。On"}, {"probability": {"variance": 0.000121, "average": 0.996274, "min": 0.961447}, "location": {"width": 212, "top": 981, "height": 36, "left": 865}, "words": "在患者最常见的不良反应"}, {"probability": {"variance": 2.8e-05, "average": 0.99742, "min": 0.971231}, "location": {"width": 845, "top": 1011, "height": 77, "left": 222}, "words": "是过敏反应,转氨酶升高,高胆红素血症,凝血功能异常。最常见的严重的不良反应是血栓(4%),"}, {"probability": {"variance": 0.000255, "average": 0.992894, "min": 0.920876}, "location": {"width": 454, "top": 1066, "height": 52, "left": 221}, "words": "需要胰岛素治疗的高糖血症(3%),和胰腺炎(1%)"}, {"probability": {"variance": 0.009175, "average": 0.965838, "min": 0.503478}, "location": {"width": 762, "top": 1106, "height": 71, "left": 261}, "words": "临床过敏反应包括:支气管痉挛、低血压、喉水肿、局部红斑或肿胀,全身性风疹和皮疹"}, {"probability": {"variance": 0, "average": 0.999265, "min": 0.998246}, "location": {"width": 138, "top": 1114, "height": 31, "left": 264}, "words": "◇临床过敏反应"}, {"probability": {"variance": 0.002315, "average": 0.982839, "min": 0.746362}, "location": {"width": 824, "top": 1164, "height": 75, "left": 265}, "words": "研究1中58名 Oncaspar治疗的患者;2名(3%)患者发生临床过敏反应。一名患者发生1级过"}, {"probability": {"variance": 0.000165, "average": 0.99524, "min": 0.949462}, "location": {"width": 282, "top": 1166, "height": 43, "left": 263}, "words": "急性淋巴细胞白血病的一线治疗"}, {"probability": {"variance": 0.009107, "average": 0.971316, "min": 0.448124}, "location": {"width": 745, "top": 1202, "height": 69, "left": 227}, "words": "敏反应,另一例患者产生3级麻疹,一例都发生在研究中延迟的强化治疗阶段(见表2)"}, {"probability": {"variance": 4e-06, "average": 0.998423, "min": 0.991908}, "location": {"width": 313, "top": 1240, "height": 48, "left": 485}, "words": "表2临床过敏反应事件及总严重程度"}, {"probability": {"variance": 0, "average": 0.999535, "min": 0.999175}, "location": {"width": 79, "top": 1279, "height": 25, "left": 662}, "words": "毒性等级"}, {"probability": {"variance": 2.5e-05, "average": 0.971832, "min": 0.966812}, "location": {"width": 38, "top": 1295, "height": 28, "left": 940}, "words": "共计"}, {"probability": {"variance": 0.0138, "average": 0.89015, "min": 0.711402}, "location": {"width": 75, "top": 1327, "height": 26, "left": 359}, "words": "患者情况"}, {"probability": {"variance": 0.000146, "average": 0.985999, "min": 0.968687}, "location": {"width": 67, "top": 1330, "height": 24, "left": 921}, "words": "20(32)"}, {"probability": {"variance": 0.001769, "average": 0.970042, "min": 0.872701}, "location": {"width": 139, "top": 1362, "height": 26, "left": 333}, "words": "既往有高敏反应史"}, {"probability": {"variance": 0.000179, "average": 0.986683, "min": 0.968281}, "location": {"width": 53, "top": 1394, "height": 23, "left": 377}, "words": "的患者"}, {"probability": {"variance": 0.000385, "average": 0.976594, "min": 0.945457}, "location": {"width": 59, "top": 1425, "height": 22, "left": 926}, "words": "11(10"}, {"probability": {"variance": 0.010686, "average": 0.938647, "min": 0.759603}, "location": {"width": 87, "top": 1457, "height": 23, "left": 364}, "words": "非高敏思"}, {"probability": {"variance": 0.009753, "average": 0.907561, "min": 0.703095}, "location": {"width": 61, "top": 1490, "height": 18, "left": 372}, "words": "(n=112"}, {"probability": {"variance": 0, "average": 0.999664, "min": 0.999384}, "location": {"width": 55, "top": 1519, "height": 21, "left": 390}, "words": "线治疗"}], "language": 3}